Published in J Anesth on January 01, 2006
Interaction of local anesthetics with biomembranes consisting of phospholipids and cholesterol: mechanistic and clinical implications for anesthetic and cardiotoxic effects. Anesthesiol Res Pract (2013) 0.81
Midazolam in rabbits terminates dysrhythmias caused by intracerebroventricular ropivacaine. J Zhejiang Univ Sci B (2011) 0.75
Differences in cardiotoxicity of bupivacaine and ropivacaine are the result of physicochemical and stereoselective properties. Anesthesiology (2002) 1.03
Adverse effects of local anaesthetics. Drug Saf (1992) 0.92
Myocardial and cerebral drug concentrations and the mechanisms of death after fatal intravenous doses of lidocaine, bupivacaine, and ropivacaine in the sheep. Anesth Analg (1989) 0.87
Comparative ventricular electrophysiologic effect of racemic bupivacaine, levobupivacaine, and ropivacaine on the isolated rabbit heart. Anesthesiology (2000) 0.86
Rescue of contractile abnormalities by Na+/Ca2+ exchanger overexpression in postinfarction rat myocytes. J Appl Physiol (1985) (2002) 0.83
Remodeling of cardiac gap junctions: the relationship to the genesis of ventricular tachycardia. J Electrocardiol (2001) 0.83
Plasma ropivacaine levels following scalp block for awake craniotomy. J Neurosurg Anesthesiol (2004) 0.82
Sodium pump inhibition in sarcolemma from ischemic hearts. J Mol Cell Cardiol (1995) 0.81
Ionic mechanisms of ischemia-related ventricular arrhythmias. Clin Cardiol (1996) 0.78
Class Ic antiarrhythmic drugs and myocardial ischaemia: study in the pig heart in situ. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.77
Enhancement by ischemia of the risk of cardiac disorders, especially fibrillation, in regional anesthesia with bupivacaine. Acta Anaesthesiol Scand (1993) 0.75
Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization. Can J Physiol Pharmacol (2000) 0.75
Effect of lidocaine on left ventricular pressure-volume curves during demand ischemia in pigs. Am J Physiol (1998) 0.75
Effects of ropivacaine on sodium, calcium, and potassium currents in guinea pig ventricular myocytes. Acta Pharmacol Sin (2002) 0.75
Changes in sarcolemmal proteins in subacute myocardial infarction in the dog. Cell Mol Biol (1992) 0.75
Prevention by calcium antagonists of profibrillatory effects of class I antiarrhythmic drugs in acute myocardial ischemia: study in pig heart in situ. Pharmacotherapy (1997) 0.75
Clinical aspects and prognosis of Brugada syndrome in children. Circulation (2007) 2.29
Identification and distribution of interstitial Cajal cells in human pulmonary veins. Heart Rhythm (2008) 1.86
Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients presenting gastrointestinal disorders: a pilot study. Liver Transpl (2006) 1.74
Quantitative study of nerves of the human left atrium. Heart Rhythm (2005) 1.59
Determinants of torsades de pointes in older patients with drug-associated long QT syndrome: a case-control study. Drugs Aging (2014) 1.50
How reliable are 40 MHz IVUS and 64-slice MDCT in characterizing coronary plaque composition? An ex vivo study with histopathological comparison. Int J Cardiovasc Imaging (2010) 1.50
Muscarinic receptor upregulation in patients with myocardial infarction: a new paradigm. Circ Cardiovasc Imaging (2009) 1.42
Pregnancy outcome after risk assessment of occupational exposure to organic solvents: a prospective cohort study. Reprod Toxicol (2010) 1.41
Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice. Europace (2010) 1.40
Contributions of remote monitoring to the follow-up of implantable cardioverter-defibrillator leads under advisory. Eur Heart J (2010) 1.21
Population pharmacokinetics of atazanavir in human immunodeficiency virus-infected patients. Ther Drug Monit (2008) 1.09
Clinical and mutational spectrum in a cohort of 105 unrelated patients with dilated cardiomyopathy. Eur J Med Genet (2011) 1.09
Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study. J Rheumatol (2004) 1.09
Toward personal eHealth in cardiology. Results from the EPI-MEDICS telemedicine project. J Electrocardiol (2005) 1.08
Immunosuppressive drugs and cancer. Toxicology (2003) 1.03
5-Fluorouracil-induced Tako-Tsubo-like syndrome. Pharmacotherapy (2011) 1.03
Cardiotoxicity of 5-fluorouracil in 1350 patients with no prior history of heart disease. Bull Cancer (2006) 1.02
Allergic adverse reactions to sulfonamides. Curr Allergy Asthma Rep (2002) 1.01
Prediction of sustained virological response by ribavirin plasma concentration at week 4 of therapy in hepatitis C virus genotype 1 patients. Antivir Ther (2008) 1.01
Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy. Eur J Med Genet (2010) 1.00
Heart lesions associated with anabolic steroid abuse: comparison of post-mortem findings in athletes and norethandrolone-induced lesions in rabbits. Exp Toxicol Pathol (2008) 0.99
Relevance of a combined UV and single mass spectrometry detection for the determination of tenofovir in human plasma by HPLC in therapeutic drug monitoring. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.99
New paradigms in telemedicine: ambient intelligence, wearable, pervasive and personalized. Stud Health Technol Inform (2004) 0.97
Evaluation of a lymph node proliferation assay for its ability to detect pharmaceuticals with potential to cause immune-mediated drug reactions. J Immunotoxicol (2005) 0.97
Hidden cardiac lesions and psychotropic drugs as a possible cause of sudden death in psychiatric patients: a report of 14 cases and review of the literature. Can J Psychiatry (2004) 0.91
Contribution of long-QT syndrome genetic variants in sudden infant death syndrome. Pediatr Cardiol (2009) 0.90
Sudden death of cardiac origin and psychotropic drugs. Front Pharmacol (2012) 0.89
Anti-viral triple therapy with telaprevir in haemodialysed HCV patients: is it feasible? J Clin Virol (2012) 0.88
Genotypic screening of the main opiate-related polymorphisms in a cohort of 139 sickle cell disease patients. Am J Hematol (2012) 0.87
Critical review of preclinical approaches to evaluate the potential of immunosuppressive drugs to influence human neoplasia. Int J Toxicol (2010) 0.87
Cidofovir plasma assays after local injection in respiratory papillomatosis. Laryngoscope (2004) 0.86
Popliteal lymph node assay: facts and perspectives. J Appl Toxicol (2005) 0.86
Clinical and histopathological progression of lesions in lupus-prone (NZB x NZW) F1 mice. Exp Toxicol Pathol (2004) 0.85
Tramadol and hypoglycaemia: comparison with other step 2 analgesic drugs. Br J Clin Pharmacol (2013) 0.85
[Acute hepatitis due to Exolise, a Camellia sinensis-derived drug]. Gastroenterol Clin Biol (2003) 0.85
Pharmacokinetic-pharmacodynamic modeling of unboosted Atazanavir in a cohort of stable HIV-infected patients. Antimicrob Agents Chemother (2012) 0.85
Proton pump inhibitor-induced neutropenia: possible cross-reactivity between omeprazole and pantoprazole. Clin Drug Investig (2010) 0.85
Extreme bradycardia due to multiple drug-drug interactions in a patient with HIV post-exposure prophylaxis containing lopinavir-ritonavir. Br J Clin Pharmacol (2011) 0.84
Tolerability of everolimus-based immunosuppression in maintenance liver transplant recipients. Clin Transplant (2010) 0.84
Design and evaluation of a transesophageal HIFU probe for ultrasound-guided cardiac ablation: simulation of a HIFU mini-maze procedure and preliminary ex vivo trials. IEEE Trans Ultrason Ferroelectr Freq Control (2013) 0.84
Inflammation, a link between obesity and atrial fibrillation. Inflamm Res (2015) 0.83
Everolimus for refractory Crohn's disease: a case report. Inflamm Bowel Dis (2008) 0.83
Salbutamol misuse or abuse with fatal outcome: a case-report. Hum Exp Toxicol (2010) 0.83
NK-cell activity in immunotoxicity drug evaluation. Toxicology (2003) 0.82
Lead poisoning following ingestion of pieces of lead roofing plates: pica-like behavior in an adult. Clin Toxicol (Phila) (2008) 0.82
Right ventricular pump function after cardiac resynchronization therapy: a strain imaging study. Arch Cardiovasc Dis (2008) 0.82
Mexiletine differentially restores the trafficking defects caused by two brugada syndrome mutations. Front Pharmacol (2012) 0.82
Long-standing bacteremia and endocarditis caused by Staphylococcus lugdunensis in a patient with an implantable cardioverter defibrillator. Clin Microbiol Infect (1997) 0.82
Feasibility of ribavirin therapeutic drug monitoring in hepatitis C. Ther Drug Monit (2009) 0.81
Ivabradine induces an increase in ventricular fibrillation threshold during acute myocardial ischemia: an experimental study. J Cardiovasc Pharmacol (2008) 0.81
Profiling sirolimus-induced inflammatory syndrome: a prospective tricentric observational study. PLoS One (2013) 0.81
QT interval prolongation in future SIDS victims: a polysomnographic study. Sleep (2008) 0.81
A new C-terminal hERG mutation A915fs+47X associated with symptomatic LQT2 and auditory-trigger syncope. Heart Rhythm (2008) 0.80
Progressive endothelial damage revealed by multilevel von Willebrand factor plasma concentrations in atrial fibrillation patients. Europace (2013) 0.80
Radiofrequency ablation of atrial fibrillation: the first 100 cases in Lyon. Int J Cardiol (2008) 0.80
Increased intracardiac vascular endothelial growth factor levels in patients with paroxysmal, but not persistent atrial fibrillation. Europace (2012) 0.80
Periatrial epicardial fat is associated with markers of endothelial dysfunction in patients with atrial fibrillation. PLoS One (2013) 0.80
Lethal acute poisoning with potassium ferrocyanide. Am J Emerg Med (2010) 0.80
Biophysical characterization of a new SCN5A mutation S1333Y in a SIDS infant linked to long QT syndrome. FEBS Lett (2009) 0.79
Cardiac retention of [11C]HED in genotyped long QT patients: a potential amplifier role for severity of the disease. Am J Physiol Heart Circ Physiol (2003) 0.79
Popliteal lymph node responses to acetone and ethanol differ from those induced by streptozotocin. Arch Toxicol (2004) 0.79
Ivabradine but not propranolol delays the time to onset of ischaemia-induced ventricular fibrillation by preserving myocardial metabolic energy status. Resuscitation (2012) 0.79
[Evidence-based therapeutic drug monitoring for efavirenz]. Therapie (2011) 0.79
Unprovoked atrial tachyarrhythmias in aging spontaneously hypertensive rats: the role of the autonomic nervous system. Am J Physiol Heart Circ Physiol (2012) 0.78
Autoimmune diseases and vaccinations. Eur J Dermatol (2004) 0.78
Cardiac lesions induced by testosterone: protective effects of dexrazoxane and trimetazidine. Cardiovasc Toxicol (2009) 0.78
Sudden death due to a cystic atrio-ventricular node tumour. J Forensic Leg Med (2010) 0.78
Ribavirin in combination therapy for HCV chronic infection in HIV patients: how to win the war after winning the first battle? J Hepatol (2007) 0.78
Heart rate reduction with ivabradine increases ischaemia-induced ventricular fibrillation threshold: role of myocyte structure and myocardial perfusion. Resuscitation (2011) 0.78
F-ara-AMP is a substrate of cytoplasmic 5'-nucleotidase II (cN-II): HPLC and NMR studies of enzymatic dephosphorylation. Nucleosides Nucleotides Nucleic Acids (2006) 0.78
Trimetazidine protective effect against ischemia-induced susceptibility to ventricular fibrillation in pigs. Cardiovasc Drugs Ther (2007) 0.78
Etifoxine-induced acute hepatitis: a case series. Clin Res Hepatol Gastroenterol (2012) 0.78